Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier
Molecular Pharmaceutics · 03.11.2025 · 22 (11) · 6395-6397
DOI: 10.1021/acs.molpharmaceut.5c01417 ↗Kurz gefasst
Editorial in der Zeitschrift Molecular Pharmaceutics, online erschienen am 03.11.2025. Verfasst von Karunya K Kandimalla. Beteiligte Einrichtung: Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United St…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Institutes of Health/National Institute of Neurological Disorders and Stroke/National Institute for Aging.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Pharmaceutics and Brain Barriers Research Center, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, United States.
ORCID-Profile: Karunya K Kandimalla
Förderung
- National Institutes of Health/National Institute of Neurological Disorders and Stroke/National Institute for Aging
Zitieren
APA
Kandimalla, K. K. (2025). Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier. Molecular Pharmaceutics, 22(11), 6395-6397. https://doi.org/10.1021/acs.molpharmaceut.5c01417
Vancouver
Kandimalla KK. Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier. Molecular Pharmaceutics. 2025;22(11):6395-6397. doi:10.1021/acs.molpharmaceut.5c01417
BibTeX
@article{Kandimalla2025,
author = {Kandimalla, Karunya K},
title = {Drug Delivery Strategies to Cross, Target, or Bypass the Blood–Brain Barrier},
journal = {Molecular Pharmaceutics},
year = {2025},
volume = {22},
number = {11},
pages = {6395--6397},
doi = {10.1021/acs.molpharmaceut.5c01417}
}
EUVIMED